BETA.NS

BETA DRUGS LIMITED

NSEHealthcare

₹2,099.00

▼ -2.63%-₹56.70 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹2,155.70

Day range

₹0 – ₹0

52W range

₹990.1 – ₹2,250

Volume

36.0K

Avg vol (20D)

49.2K

Mkt cap

₹2,119.12Cr

P/E TTM

51.0×

Trade BETA DRUGS LIMITED with Artha

Company Metrics

Revenue (ttm)₹384.83 Cr

Net Income (ttm)₹0.00

Shares Out1.01 Cr

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta-0.52

About BETA.NS

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolBETA.NS

Websitehttps://betadrugslimited.com

BETA.NS · NSE

Financial Performance

In 2026, BETA DRUGS LIMITED's revenue was ₹384.83 Cr, an increase of +0.20% compared to the previous year. Earnings were ₹0.00, an decrease of +5.00%.

Revenue (2026)

₹384.83 Cr

↗+0.20% YoY

Earnings (2026)

₹0.00

↘-5.00% YoY

Year-over-Year Growth

Revenue

+0.20%

Earnings

-5.00%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account